Riyadh, King Faisal Specialist Hospital and Research Centre (KFSHRC) said in a press release issued today that it has won the 2024 Value-Based Healthcare Prize, a recognition presented by the Value-Based Health Care Centre Europe.
This accolade for KFSHRC’s pioneering Home Hemodialysis (HHD) initiative underscores its commitment to comprehensive healthcare. It is a testament to KFSHRC’s patient-centric approach, designed to address the unique needs of kidney patients with advanced medical conditions, physical disabilities, and mobility challenges. This comprehensive system of continuous and supportive care, delivered in the comfort of patients’ homes, ensures the highest standards of safety and comfort and significantly improves their quality of life, said the release.
The chairman of the Internal Medicine Department at KFSHRC in Jeddah and the leading physician for the Home Hemorrhodialysis initiative, Dr. Wael Habhab, said, “The initial outcomes of the initiative revealed a substantial reduction in emerge
ncy room visits and hospital admissions, as well as lower re-hospitalization rates.”
He also confirmed that the initiative has greatly alleviated the burden of managing medications for bone and mineral diseases associated with chronic kidney failure, alongside a decreased need for intravenous medication injections.
The award is granted to healthcare institutions that offer innovative solutions, contribute to tangible outcomes, reduce costs, and enhance patient value.
KFSHRC has been ranked first in the Kingdom and 20th globally in the world’s top 250 healthcare institutions. According to the 2024 Brand Finance rankings, it is recognized as the most valuable healthcare brand in the Kingdom and the Middle East. The release said the prestigious Newsweek magazine ranked it among the world’s best hospitals.
Source: Saudi Press Agency
